Axel Cangas/LinkedIn
Jul 19, 2026, 16:58
Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
Axel Cangas, Hematology and Immunology Unit Head at Roche México, shared a post on LinkedIn:
”Thrilled to be at International Society on Thrombosis and Haemostasis (ISTH) 2026 engaging with global experts on the incredible scientific advancements redefining haemophilia care.
It has been inspiring to see Roche’s deep, long-term commitment to this community.
We remain dedicated to standing alongside patients, families, and healthcare professionals for generations to come.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question